BSE Live
Dec 31, 16:01Prev. Close
62.36
Open Price
62.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.84 | -0.64 | -2.48 | 0.81 | 0.58 | |
| Diluted EPS (Rs.) | 0.84 | -4.87 | -2.48 | 0.81 | 0.58 | |
| Cash EPS (Rs.) | 4.67 | 0.11 | -2.16 | 1.56 | 1.11 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 89.13 | 88.29 | -0.42 | 1.64 | 0.58 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 89.13 | 88.29 | -0.42 | 1.64 | 0.58 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 16.45 | 28.15 | 5.03 | 7.38 | 10.98 | |
| PBDIT/Share (Rs.) | 5.55 | 0.62 | 0.53 | 0.33 | 1.38 | |
| PBIT/Share (Rs.) | 1.71 | -4.36 | -0.19 | -0.17 | 1.02 | |
| PBT/Share (Rs.) | 1.71 | -4.45 | -0.22 | -0.19 | 0.76 | |
| Net Profit/Share (Rs.) | 0.84 | -4.87 | -2.88 | 1.06 | 0.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 33.72 | 2.19 | 10.53 | 4.44 | 12.58 | |
| PBIT Margin (%) | 10.42 | -15.48 | -3.72 | -2.28 | 9.33 | |
| PBT Margin (%) | 10.37 | -15.80 | -4.29 | -2.55 | 6.90 | |
| Net Profit Margin (%) | 5.08 | -17.30 | -57.31 | 14.38 | 6.90 | |
| Return on Networth / Equity (%) | 0.93 | -5.51 | 0.00 | 64.74 | 131.05 | |
| Return on Capital Employed (%) | 0.75 | -4.68 | -1.61 | 6.78 | 27.20 | |
| Return on Assets (%) | 0.71 | -4.29 | -21.64 | 5.97 | 6.02 | |
| Total Debt/Equity (X) | 0.09 | 0.02 | -23.49 | 7.12 | 10.07 | |
| Asset Turnover Ratio (%) | 14.06 | 24.84 | 37.76 | 41.56 | 87.27 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 7.87 | 4.46 | 1.93 | 7.13 | 1.02 | |
| Quick Ratio (X) | 6.32 | 3.67 | 1.23 | 6.65 | 0.95 | |
| Inventory Turnover Ratio (X) | 1.91 | 3.88 | 4.15 | 7.23 | 15.36 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.85 | 0.04 | 11.40 | 12.75 | 5.44 | |
| EV/Net Operating Revenue (X) | 0.33 | 0.01 | 2.23 | 1.92 | 0.55 | |
| EV/EBITDA (X) | 0.98 | 0.44 | 21.17 | 43.28 | 4.39 | |
| MarketCap/Net Operating Revenue (X) | 0.10 | 0.06 | 0.27 | 0.35 | 0.05 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | |
| Price/BV (X) | 0.02 | 0.02 | -3.17 | 1.56 | 0.87 | |
| Price/Net Operating Revenue | 0.10 | 0.06 | 0.27 | 0.35 | 0.05 | |
| Earnings Yield | 0.53 | -3.10 | -2.15 | 0.41 | 1.51 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y